lncRNA CHAF1B-2 and its Role in Gastric Cancer
Author Information
Author(s): Tian Shao-Qi, Shen Jun-Jie, Sun Dao-Ping, Chen Wen-Ming
Primary Institution: Department of Oncology, Jining Hospital of Xiyuan Hospital of CACMS
Hypothesis
Lnc-CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway.
Conclusion
Lnc-CHAF1B-2 is upregulated in gastric cancer tissues and negatively correlates with patient prognosis.
Supporting Evidence
- Lnc-CHAF1B-2 was significantly upregulated in gastric cancer tissues compared to adjacent noncancerous tissues.
- There was a positive correlation between lnc-CHAF1B-2 levels and the occurrence of distant metastases in patients.
- High expression of lnc-CHAF1B-2 was significantly negatively correlated with overall survival and disease-specific survival of patients.
- Lnc-CHAF1B-2 enhanced the proliferation, invasion, and migration of gastric cancer cells while inhibiting apoptosis.
Takeaway
A molecule called lnc-CHAF1B-2 helps cancer cells grow and spread in stomach cancer, making it a potential target for new treatments.
Methodology
The study used bioinformatics analysis of RNA-seq data, in vivo and in vitro experiments including EdU incorporation, flow cytometry, trans-well migration and invasion assays, and western blot analysis.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.844–0.937
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website